The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Alnylam Pharmaceuticals Inc shares valued at $1,633,500 were sold by Garg Pushkal on Mar 24 ’25. At $300.00 per share, Garg Pushkal sold 5,445 shares. The insider’s holdings dropped to 20,221 shares worth approximately $5.48 million following the completion of this transaction.
Also, Garg Pushkal sold 4,321 shares, netting a total of over 1,231,485 in proceeds. Following the sale of shares at $285.00 each, the insider now holds 20,221 shares.
Before that, PYOTT DAVID E I had sold 7,440 shares from its account. In a trade valued at $2,224,560, the Director traded Alnylam Pharmaceuticals Inc shares for $299.00 each. Upon closing the transaction, the insider’s holdings decreased to 7,440 shares, worth approximately $36858.72.
As published in a research note from JP Morgan on March 24, 2025, Alnylam Pharmaceuticals Inc [ALNY] has been rated up from a Neutral to an Overweight and the price target has been revised to $328 from $280. Analysts at Wolfe Research downgraded the stock from ‘”a Peer perform”‘ to ‘”an Underperform”‘ outlook in a report released in mid November. As of October 16, 2024, Scotiabank has initiated its “Sector outperform” rating for ALNY. Earlier on August 16, 2024, Goldman upgraded its rating. Their new recommendation was “a Buy” for ALNY stock which previously was a “a Neutral”.
Analyzing ALNY Stock Performance
During the last five days, there has been a surge of approximately 6.89%. Over the course of the year, Alnylam Pharmaceuticals Inc shares have jumped approximately 15.18%. Shares of the company reached a 52-week high of $300.90 on 03/24/25 and a 52-week low of $230.79 on 03/11/25. A 50-day SMA is recorded $259.34, while a 200-day SMA reached $254.99.
Support And Resistance Levels for Alnylam Pharmaceuticals Inc (ALNY)
According to the 24-hour chart, there is a support level at 264.58, which, if violated, would cause prices to drop to 258.13. In the upper region, resistance lies at 277.02. The next price resistance is at 283.01. RSI (Relative Strength Index) is 57.28 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 16.77, which suggests the price will increase in the coming days. Percent R is at 42.62%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
